Commission Implementing Regulation (EU) 2026/2203

Contents

THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products^note, and in particular Article 50(2) thereof,Whereas:

(1)On 3 September 2024, Commission Implementing Regulation (EU) 2024/2175^note granted a Union authorisation, under number EU-0032017-0000, to Contec Europe for the making available on the market and use of the biocidal product family ‘Contec Calcium Hypochlorite Product Family’. The Annex to that Implementing Regulation provides the summary of product characteristics (‘SPC’) for that biocidal product family.

(2)On 24 December 2024, Contec Europe submitted to the European Chemicals Agency (‘the Agency’), in accordance with Article 12(1) of Commission Implementing Regulation (EU) No 354/2013^note, an application for minor changes to the Union authorisation for the biocidal product family ‘Contec Calcium Hypochlorite Product Family’, as referred to in Title 2 of the Annex to that Regulation. The application was recorded in the Register for Biocidal Products under case number BC-BE102191-75. The proposed changes to that authorisation concern the extension of the shelf life of products, the inclusion of yeasticidal claim in meta SPC 1 and the increase of contact time in meta SPC 1.

(3)On 3 October 2025, the Agency submitted, in accordance with Article 12(4) of Implementing Regulation (EU) No 354/2013, an opinion^note on the proposed minor changes to the Union authorisation for the biocidal product family ‘Contec Calcium Hypochlorite Product Family’ together with a revised summary of product characteristics and a revised assessment report. The opinion concludes that the proposed changes are minor changes as referred to in Article 3(1) (ab) and Article 50(3), point (b), of Regulation (EU) No 528/2012 and as specified in Title 2 of the Annex to Implementing Regulation (EU) No 354/2013, and that after the implementation of the changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.

(4)On 31 October 2025, the Agency transmitted to the Commission the revised summary of product characteristics of the Union authorisation for the biocidal product family ‘Contec Calcium Hypochlorite Product Family’ in all official languages of the Union, covering the minor changes applied for, in accordance with Article 12(6) of Implementing Regulation (EU) No 354/2013.

(5)The Commission concurs with the opinion of the Agency and therefore considers it appropriate to adapt the Union authorisation for the biocidal product family ‘Contec Calcium Hypochlorite Product Family’ to introduce the minor changes sought by Contec Europe.

(6)In order to enhance clarity and to ease the access of users and interested parties to the consolidated version of the summary of product characteristics which is to be published by the Agency, the Annex to Implementing Regulation (EU) 2024/2175 should be replaced in its entirety.

(7)Implementing Regulation (EU) 2024/2175 should therefore be amended accordingly,

HAS ADOPTED THIS REGULATION:

Commission Implementing Regulation (EU) 2026/2203

Key facts

Connections

History · 1 version